Premenopausal antimüllerian hormone concentration is associated with subsequent atherosclerosis

Objective The aim of this study was to determine if premenopausal ovarian reserve is associated with susceptibility for atherosclerosis. Methods Female cynomolgus macaques (n = 66, women’s equivalent age = 45 y) consumed an atherogenic diet for ∼5 months before the measurement of a marker of ovarian reserve (antimüllerian hormone [AMH]), plasma lipids, follicular phase estradiol, and body weight (BW). Monkeys were then ovariectomized (OVX; n = 17), remained premenopausal (n = 20), or were induced to have reduced ovarian reserve (ROR, n = 29). After 26 additional months consuming the diet, atherosclerosis measurements and risk variables were reassessed. Results No differences in baseline AMH, plasma lipids, BW, and estradiol or postdiet lipids and BW were observed among the groups subsequently assigned to the OVX, premenopausal control, or reduced ovarian reserve conditions. Postdiet measurements of atherosclerosis extent did not differ among the groups. However, analysis of plaque size by tertile of baseline AMH revealed that plaques were largest in monkeys that began the experiment with the lowest baseline AMH, followed by those in the middle and high tertiles (plaque extent: low AMH, 0.76 ± 0.12 mm2; mid AMH, 0.46 ± 0.1 mm2; high AMH, 0.34 ± 0.08 mm2; P = 0.02). Baseline AMH and plaque size were also correlated negatively (r = −0.31, P = 0.01). Plasma lipids were also correlated significantly with plaque extent (all P < 0.01) but not with AMH. Conclusions We report for the first time an inverse relationship between a marker of ovarian reserve (AMH) and subsequent atherosclerosis risk.

[1]  N. Klein,et al.  Ovarian primordial and nongrowing follicle counts according to the Stages of Reproductive Aging Workshop (STRAW) staging system , 2012, Menopause.

[2]  C. Lebrun.  Cardiovascular Consequences of Ovarian Disruption: A Focus on Functional Hypothalamic Amenorrhea in Physically Active Women , 2012 .

[3]  E. Vittinghoff,et al.  Risk factor and prediction modeling for sudden cardiac death in women with coronary artery disease. , 2011, Archives of internal medicine.

[4]  J. Cline,et al.  Endocrine profile of an ovariectomized cynomolgus monkey (Macaca fascicularis) with a supernumerary ovary. , 2011, Comparative medicine.

[5]  J. Goodman,et al.  Clinical review: Cardiovascular consequences of ovarian disruption: a focus on functional hypothalamic amenorrhea in physically active women. , 2011, The Journal of clinical endocrinology and metabolism.

[6]  Y. Hwu,et al.  The predictability of serum anti-Müllerian level in IVF/ICSI outcomes for patients of advanced reproductive age , 2011, Reproductive biology and endocrinology : RB&E.

[7]  M. Eijkemans,et al.  Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. , 2011, The Journal of clinical endocrinology and metabolism.

[8]  S. Kılıc,et al.  Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization , 2011, Archives of Gynecology and Obstetrics.

[9]  W. Mack,et al.  A “window of opportunity:” The reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent , 2011, Brain Research.

[10]  L. Shulman.  A “window of opportunity:” The reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent , 2011 .

[11]  N. Knowlton,et al.  Correlation of ovarian reserve tests with histologically determined primordial follicle number. , 2011, Fertility and sterility.

[12]  S. Manuck,et al.  Impairment of ovarian function and associated health-related abnormalities are attributable to low social status in premenopausal monkeys and not mitigated by a high-isoflavone soy diet. , 2010, Human reproduction.

[13]  P. Hoyer,et al.  Experimental induction of reduced ovarian reserve in a nonhuman primate model (Macaca fascicularis). , 2010, Comparative medicine.

[14]  N. Santoro,et al.  Characterizing the reproductive hormone milieu in infertile women with diminished ovarian reserve. , 2010, Fertility and sterility.

[15]  D. Mozaffarian,et al.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[16]  T. Clarkson,et al.  Coronary heart disease of females: lessons learned from nonhuman primates , 2009, American journal of primatology.

[17]  M. Solaymani-Dodaran,et al.  A single test of antimüllerian hormone in late reproductive-aged women is a good predictor of menopause , 2009, Menopause.

[18]  P. Hoyer,et al.  Serum antimüllerian hormone predicts ovarian reserve in a monkey model , 2009, Menopause.

[19]  J. Manson,et al.  Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study , 2009, Obstetrics and gynecology.

[20]  S. Oparil,et al.  Estrogen and mechanisms of vascular protection. , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[21]  A. Meikle.  Anti-Mullerian Hormone and Inhibin B in the Definition of Ovarian Aging and the Menopause Transition , 2009 .

[22]  P. Sonderegger,et al.  Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin , 2008, Journal of Cell Science.

[23]  J. Visser,et al.  Correlation of serum anti-Müllerian hormone with accelerated follicle loss following 4-vinylcyclohexene diepoxide-induced follicle loss in mice. , 2008, Reproductive toxicology.

[24]  P. Hoyer,et al.  Development of an animal model for ovotoxicity using 4-vinylcyclohexene: a case study. , 2007, Birth defects research. Part B, Developmental and reproductive toxicology.

[25]  Andrew P. Miller,et al.  Aged rats lose vasoprotective and anti-inflammatory actions of estrogen in injured arteries , 2007, Menopause.

[26]  H. Urbanski,et al.  Neuroendocrine Changes in the Aging Reproductive Axis of Female Rhesus Macaques (Macaca mulatta)1 , 2006, Biology of reproduction.

[27]  D. Bhartiya,et al.  Developmental expression and cellular distribution of Mullerian inhibiting substance in the primate ovary. , 2006, Reproduction.

[28]  D. Grobbee,et al.  Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis , 2006, Menopause.

[29]  M. Budoff,et al.  Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. , 2006, Atherosclerosis.

[30]  Edward G Lakatta,et al.  Arterial aging: is it an immutable cardiovascular risk factor? , 2005, Hypertension.

[31]  J. Visser,et al.  Anti-Müllerian hormone and folliculogenesis , 2005, Molecular and Cellular Endocrinology.

[32]  Kim Wallen,et al.  Medroxyprogesterone acetate antagonizes the effects of estrogen treatment on social and sexual behavior in female macaques. , 2004, The Journal of clinical endocrinology and metabolism.

[33]  E. Lakatta,et al.  Aging Increases Aortic MMP‐2 Activity and Angiotensin II in Nonhuman Primates , 2003, Hypertension.

[34]  Daniel Levy,et al.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. , 2003, Circulation.

[35]  B. Fauser,et al.  Antimüllerian hormone serum levels: a putative marker for ovarian aging. , 2002, Fertility and sterility.

[36]  M. Anthony,et al.  Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens. , 2001, The Journal of clinical endocrinology and metabolism.

[37]  B. Gülekli,et al.  Accuracy of ovarian reserve tests. , 1999, Human reproduction.

[38]  T. B. Clarkson.  Nonhuman primate models of atherosclerosis. , 2012, Laboratory animal science.

[39]  T. Clarkson,et al.  Effects of the anabolic steroid nandrolone decanoate on plasma lipids and coronary arteries of female cynomolgus macaques. , 1996, Metabolism: clinical and experimental.

[40]  S. Manuck,et al.  Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[41]  T. Clarkson,et al.  Ovariectomy, Social Status, and Atherosclerosis in Cynomolgus Monkeys , 1985, Arteriosclerosis.

[42]  T. Clarkson,et al.  Psychosocial influences on female 'protection' among cynomolgus macaques. , 1984, Atherosclerosis.